DM news out
Revive Therapeutics working on Datametrex AI component
2017-12-04 10:39 ET - News Release
See News Release (C-RVV) Revive Therapeutics Ltd
Mr. Craig Leon of Revive reports
REVIVE THERAPEUTICS ANNOUNCES UPDATE ON DEVELOPMENT OF DATAMETREX ARTIFICIAL INTELLIGENCE COMPONENT IN BLOCKCHAIN ENABLED PATIENT-FOCUSED PROGRAM FOR MEDICAL CANNABIS SECTOR
Revive Therapeutics Ltd. has provided an update on the development of the artificial intelligence (AI) component for Revive's proposed proprietary patient-focused program dedicated to the medical cannabis industry enabled by blockchain technology. This update follows Datametrex AI Limited ("Datametrex") (TSX VENTURE:DM)(FRANKFURT:D4G) recent announcement of Datametrex's wholly owned subsidiary, Nexalogy Environics Inc. ("Nexalogy"), entered into a license and development agreement with Revive.